|
Volumn 42, Issue 6, 2003, Pages 468-475
|
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
AMOXICILLIN;
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
BENZIMIDAZOLE DERIVATIVE;
CLARITHROMYCIN;
CYP2C19 PROTEIN, HUMAN;
DRUG DERIVATIVE;
MIXED FUNCTION OXIDASE;
OMEPRAZOLE;
PROTON PUMP;
RABEPRAZOLE;
UNSPECIFIC MONOOXYGENASE;
ADULT;
AGED;
ARTICLE;
DRUG ANTAGONISM;
DRUG COMBINATION;
DUODENUM ULCER;
FEMALE;
GENETICS;
GENOTYPE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
STOMACH ULCER;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
AGED;
AMOXICILLIN;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
ARYL HYDROCARBON HYDROXYLASES;
BENZIMIDAZOLES;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
DUODENAL ULCER;
FEMALE;
GENOTYPE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
MIDDLE AGED;
MIXED FUNCTION OXYGENASES;
OMEPRAZOLE;
PROTON PUMPS;
STOMACH ULCER;
|
EID: 2142686146
PISSN: 15989992
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (20)
|
References (0)
|